PHOENIX, Oct. 17, 2024 (GLOBE NEWSWIRE) - WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced th......
Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjugate
-- BPT567 is the first bifunctional PD1-IL18 ......
